Showing results 1 to 20 of 31
next >
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Aptamer-based inhibitor of sclerostin for Osteoporosis Therapy Proceeding/Conference:Research Postgraduate Symposium, RPS 2009 | 2009 | 146 | ||
Aptamer-mediated Inhibition of Mycobacterium tuberculosis Polyphosphate Kinase 2 Proceeding/Conference:Hong Kong Chemical Biology Symposium | 2009 | 245 | ||
Aptamer-mediated inhibition of mycobacterium tuberculosis polyphosphate kinase 2 Journal:Biochemistry | 2011 | 352 | ||
Aptamer-mediated inhibition of Mycobacterium tuberculosis polyphosphate kinase 2 Proceeding/Conference:Hong Kong Inter-University Biochemistry Postgraduate Symposium | 2010 | 258 | ||
Aptamers against polyphosphate kinase 2 (PPK2) from mycobacterium tuberculosis as a potential approach of novel anti-tuberculosis therapy Proceeding/Conference:Croucher Foundation ASI Conference on Structure-Based Screening & Design of Ligands for Protein Targets | 2009 | 132 | ||
Bismuth complexes inhibit the SARS coronavirus Journal:Angewandte Chemie - International Edition | 2007 | 576 | ||
Chemical biology Book:Kirk-Othmer Encyclopedia of Chemical Technology | 2010 | 156 | ||
Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase. Journal:Chembiochem : a European journal of chemical biology | 2008 | 199 | ||
Dissecting the mechanism of binding between polyphosphate and polyphosphate kinase 2 Proceeding/Conference:Hong Kong Inter-University Postgraduate Symposium | 2012 | 158 | ||
Dissecting the mechanism of how mycobacterium tuberculosis polyphosphate kinase 2 binds to polyphosphate Proceeding/Conference:Annual Meeting of the European Molecular Biology Organisation, EMBO 2013 | 2013 | 45 | ||
DNA aptamers binding H5N1 virus nucleoprotein showed antiviral effects Proceeding/Conference:Keystone Symposia on Molecular and Cellular Biology 2011: Evolving Approaches to Early-Stage Drug Discovery | 2011 | 147 | ||
Effect of inorganic polyphosphate on higher eukaryotic cells Proceeding/Conference:Research Postgraduate Symposium, RPS 2009 | 2009 | 101 | ||
G-quadruplex aptamers inhibit sclerostin for osteoporosis therapy Proceeding/Conference:Croucher Foundation ASI Conference on Structure-Based Screening & Design of Ligands for Protein Targets | 2009 | 135 | ||
G-quadruplex DNA aptamers and their ligands: Structure, function and application Journal:Current Pharmaceutical Design | 2012 | 197 | ||
Identification of a DNA aptamer that inhibits sclerostin's antagonistic effect on Wnt signalling Journal:Biochemical Journal | 2011 | 231 | ||
In vitro aptamer selection against the SARS Coronavirus Helicase Proceeding/Conference:Annual Symposium of the Hong Kong Proteomics Society, HKPS 2007 | 2007 | 97 | ||
In vitro aptamer selection against the SARS coronavirus helicase and their intracellular delivery Proceeding/Conference:Annual Meeting of the Oligonucleotide Therapeutic Society, OTS 2007 | 2007 | 95 | ||
In vitro selection of DNA aptamers binding H5N1 Virus nucleoprotein Proceeding/Conference:Research Postgraduate Symposium, RPS 2008 | 2008 | 111 | ||
Inhibiting sclerostin with a nucleic acid aptamer as a new approach to osteoporosis therapy Proceeding/Conference:Johnson & Johnson Asia Outstanding Graduate Thesis Award in Bio-tech | 2011 | 125 | ||
Inorganic polyphosphate triggers interleukin 11 production in osteoblasts cell signalling Proceeding/Conference:The FEBS Journal | 2013 | 64 |